The Effectiveness Of Auricular Acupressure On Body Weight Parameters On Patients With Schizophrenia
1 other identifier
interventional
86
1 country
1
Brief Summary
The purpose of this study is to examine whether auricular acupressure is effective in reducing body weight, waist circumference, or lipid profile.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable schizophrenia
Started Jun 2010
Shorter than P25 for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 16, 2010
CompletedFirst Posted
Study publicly available on registry
July 22, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2010
CompletedJuly 23, 2010
July 1, 2010
2 months
July 16, 2010
July 22, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Using Body weight scale (kilogram) and checking body weight for all participants
all participants are going to be measured body weight per week for 2 months.
2 months
Secondary Outcomes (2)
waist circumference
2 months
Fat percentage by using bio-Impedance Analysis(Tanita-519 machine)
2 months
Interventions
Investigator will put a tape with a 0.5mmx0.5mm seed on the specific positions on the ear of participants of intervention group, and participants will be asked to press these specific positions 3 times a day.
Eligibility Criteria
You may qualify if:
- ICD:295,living in chronic ward for more than 2 month
- Body Mass Index (BMI) \>or=24
- Age between 20 to 60
- Psychotic status stable and can communicate
You may not qualify if:
- Unstable psychotic status
- Participants who have endocrine disease
- Participants who have cardiac disease
- Participants who have immunological disease
- Participants who have liver or renal function impairment
- Pregnant woman or in milking stage
- Cerebrovascular accident (CVA) stroke and disability
- Participant who attends weight control programs in recent 3 months
- Any conditions that clinical doctors refuse to let join in this study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tsao-Tun Psychiatric Center
Nantou City, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ching Han-Yi, MD
Tsaotun Psychiatric Center
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 16, 2010
First Posted
July 22, 2010
Study Start
June 1, 2010
Primary Completion
August 1, 2010
Study Completion
August 1, 2010
Last Updated
July 23, 2010
Record last verified: 2010-07